Peripheral Nerve Blocks for Amputations
Trial Summary
What is the purpose of this trial?
Surgery performed with nerve blocks and sedation may be safer and provide better pain control compared to general anesthesia and opioid therapy in high-risk patient populations such as elderly and troubled with peripheral vascular disease, diabetes, hypertension, coronary artery disease, and chronic obstructive pulmonary disease (COPD).
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does exclude people who use opioids regularly. If you are on opioids, you may need to stop them to participate.
What data supports the effectiveness of this treatment for amputations?
Research shows that using peripheral nerve blocks, which involve numbing specific nerves to reduce pain, can be an effective alternative to general anesthesia for lower limb amputations. These blocks can help control pain after surgery and may offer benefits over traditional methods, especially in high-risk patients.12345
Is peripheral nerve block generally safe for humans?
How is the treatment of peripheral nerve blocks unique for amputations?
Peripheral nerve blocks are unique for amputations because they provide targeted pain relief by numbing specific nerves, which can be especially beneficial for high-risk patients who may not tolerate general anesthesia well. This approach allows patients to remain awake and maintain stable vital signs during surgery, reducing the risk of complications.12111213
Research Team
José R Soberón, MD
Principal Investigator
Malcom Randall VA Medical Center
Eligibility Criteria
This trial is for patients needing above-the-knee amputations who can understand and agree to the study. It's not for those with chronic opioid use, severe liver issues, a BMI over 35, sensorimotor deficits, or true allergies to local anesthetics or sedatives.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive peripheral nerve blocks and intravenous sedatives for above-the-knee amputations
Immediate Post-operative Monitoring
Participants are monitored for pain scores and satisfaction within 48 hours post procedure
Follow-up
Participants are monitored for safety and effectiveness, including 30-day mortality assessment
Treatment Details
Interventions
- Intravenous Sedatives
- Lateral Femoral Cutaneous Nerve Blocks
- Obturator Nerve Blocks
- Peripheral Nerve Block
Peripheral Nerve Block is already approved in European Union, United States, Canada, Japan for the following indications:
- Pain control after fracture surgery
- Postoperative pain management
- Chronic pain management
- Pain control after fracture surgery
- Postoperative pain management
- Chronic pain management
- Acute pain management
- Pain control after fracture surgery
- Postoperative pain management
- Chronic pain management
- Pain control after fracture surgery
- Postoperative pain management
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor
US Department of Veterans Affairs
Collaborator